[Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia].
Animal research · 2011
- What was studied
- Rats with experimental chronic brain ischemia
- Main finding
- Cortagen and Cortexin accelerated recovery of disturbed behavior and reduced oxidative-stress changes.
Study data at a glance
- Participants or experimental model
- Rats with experimental chronic brain ischemia
- Reported results
- Cortagen and Cortexin accelerated recovery of disturbed behavior and reduced oxidative-stress changes.
Study limitations and source details
Study limitations
- Chronic experimental ischemia is not an acute-stroke trial or evidence of human benefit.
- Full methods, reporting completeness and independent replication remain to be appraised.
Source details
Original journal report
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Abstract reviewed
Sources checked
Citation
Zarubina IV, Shabanov PD. [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]. Eksperimental'naia i klinicheskaia farmakologiia · PMID 21476278
Related compounds
Cortagen
A synthetic tetrapeptide, Ala–Glu–Asp–Pro (AEDP), developed through research on Cortexin, a peptide mixture extracted from cerebral cortex.
Cortexin
A polypeptide extract of animal cerebral cortex. Its active material is a mixture of low-molecular-weight peptides studied in neurological rehabilitation, stroke and pediatric neurology.